Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Eton Pharmaceuticals, Inc. (ETON) had Operating Cash Flow per Share of $0.39 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$79.95M |
|
$-4.60M |
|
$37.21M |
|
$42.74M |
|
$80.79M |
|
$-0.84M |
|
$-3.71M |
|
$-4.56M |
|
$-4.56M |
|
$-4.60M |
|
$-4.60M |
|
$-4.60M |
|
$-4.60M |
|
$-0.84M |
|
$3.90M |
|
26.91M |
|
26.91M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$60.58M |
|
$0.33M |
|
$31.53M |
|
$92.11M |
|
$38.49M |
|
$21.77M |
|
$27.47M |
|
$65.96M |
|
$26.15M |
|
$-4.72M |
|
$26.15M |
|
27.05M |
|
| Cash Flow Statement Financials | |
$10.52M |
|
$-0.33M |
|
$0.81M |
|
$14.94M |
|
$25.94M |
|
$11.01M |
|
$5.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.57 |
|
-- |
|
-- |
|
0.45 |
|
1.17 |
|
53.46% |
|
-1.06% |
|
-1.06% |
|
4.87% |
|
-5.70% |
|
-5.75% |
|
$10.19M |
|
-- |
|
-- |
|
-- |
|
0.87 |
|
2.41 |
|
6.80 |
|
53.67 |
|
-17.59% |
|
97.40% |
|
-4.99% |
|
-9.60% |
|
$0.97 |
|
$0.38 |
|
|
Operating Cash Flow per Share |
$0.39 |